Article
Thrombocytopenia-associated mutations in the ANKRD26 regulatory region induce MAPK hyperactivation.
The Journal of clinical investigation - 1 Feb 2014
Bluteau Dominique, Balduini Alessandra, Balayn Nathalie, Currao Manuela, Nurden Paquita, Deswarte Caroline, Leverger Guy, Noris Patrizia, Perrotta Silverio, Solary Eric, Vainchenker William, Debili Najet, Favier Remi, Raslova Hana
Abstract excerpt
Point mutations in the 5' UTR of ankyrin repeat domain 26 (ANKRD26) are associated with familial thrombocytopenia 2 (THC2) and a predisposition to leukemia. Here, we identified underlying mechanisms of ANKRD26-associated thrombocytopenia. Using megakaryocytes (MK) isolated from THC2 patients and healthy subjects, we demonstrated that THC2-associated mutations in the 5' UTR of ANKRD26 resulted in loss of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
